ARIHANTACA.NS,0P0001Q8CK,8000

ARIHANTACA · General/Diversified · NSE

₹145

Current Market Price

Near Fair Value

Fair Value (DCF)

₹161

Margin of Safety

+11.1%

Updated 9h ago

DCF Sensitivity →

YieldIQ Score

73/100

Piotroski F-Score

8/9

Economic Moat

Moderate

Confidence

59%

ROE

Debt/Equity

0.00

WACC

11.1%

Market Cap

₹88 Cr

Quality & Valuation

Neutral model outputs — no recommendations.

ROCE

Return on capital employed

EV / EBITDA

Enterprise multiple

Debt / EBITDA

Leverage vs earnings

Interest Coverage

EBIT covers interest

Current Ratio

Short-term liquidity

Asset Turnover

0.93×

Revenue per ₹ of assets

Revenue CAGR (3Y)

38.7%

3-year revenue growth

Revenue CAGR (5Y)

5-year revenue growth

DCF Scenario Analysis

vs CMP ₹145.05

Bear case

₹100.16

MoS -44.8%

Base case

₹161.22

MoS +10.0%

Bull case

₹201.79

MoS +28.1%

Ratio Trends

Historical ratio trends for ARIHANTACA are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.

Historical Financials

Historical financials for ARIHANTACA are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.

Peer Comparison

Peers not yet ranked for ARIHANTACA. Comparable companies and side-by-side valuation will appear here once the peer set is established.

Dividend History

No dividend events recorded for ARIHANTACA in the last 10 years.

AI Analysis Summary

Model-generated description of metrics. Not investment advice. ARIHANTACA.NS,0P0001Q8CK,8000 (ARIHANTACA.NS) trades at 145.05 vs a model fair value of 161.22, a gap of 11.1%. Piotroski F-score: 8/9. M...

Read full AI analysis →

Run Full Interactive Analysis

Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.

Analyse ARIHANTACANow →

Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.